InsidersTradesSigma
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Insider track record
CEODisclosed buys
2
Disclosed sells
0
T+90 hit rate
82%
T+90 mean return
+18.2%
Across 11 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the complete record of transactions filed by THERO JOHN F, Chief Executive Officer. Director active across 2 companies, notably Amarin CORP Plc\uk. In total, 13 filings have been published. Split: 2 buys · 0 sell. Total volume traded: €19k. History available since 10 May 2022. The latest transaction was filed on 8 February 2024 (Levée d'options). Regulator: SEC (Form 4). The full history is openly available.
Declarations13 total
12,828 shares@ US$1.6951.4% of flowCommon StockSEC:0001209191-24-003090:0
10,000 shares@ US$2.00100.0% of flowCommon StockSEC:0001209191-22-028578:0
Ideal exit: 4 Feb 2023 (T+270)
6,736 sharesOrdinary SharesSEC:0001562180-21-005143:0
6,736 sharesOrdinary SharesSEC:0001562180-21-005143
6,736 sharesOrdinary SharesSEC:0001562180-21-004737:0
6,736 sharesOrdinary SharesSEC:0001562180-21-004737
6,736 sharesOrdinary SharesSEC:0001562180-21-003848
6,736 sharesOrdinary SharesSEC:0001562180-21-003848:0
25,000 sharesOrdinary SharesSEC:0001209191-16-095108:0
Ideal exit: 28 Oct 2016 (T+270)
169,500 sharesOrdinary SharesSEC:0001209191-16-094735:0
260,000 sharesOrdinary SharesSEC:0001209191-16-094735:1
172,157 sharesOrdinary SharesSEC:0001209191-16-094735:2
37,500 sharesOrdinary SharesSEC:0001209191-16-087894:0
13 of 13 declarations
About THERO JOHN F
John F. Thero is the President and CEO of Amarin Corp PLC and Cyteir Therapeutics, Inc. He is responsible for the strategic direction and management of operations for both companies. His experience in the biopharmaceutical sector is essential for guiding Amarin and Cyteir towards growth and innovation.
